Michael J. Catelani's most recent trade in Anixa Biosciences Inc was a trade of 9,289 Common Stock done at an average price of $2.1 . Disclosure was reported to the exchange on Jan. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anixa Biosciences Inc | Michael J. Catelani | President, COO, & CFO | Purchase of securities on an exchange or from another person at price $ 2.15 per share. | 15 Jan 2025 | 9,289 | 44,500 (0%) | 0% | 2.1 | 19,971 | Common Stock |
| Anixa Biosciences Inc | Michael J. Catelani | President, COO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 350,000 | 350,000 | - | - | Employee Stock Option | |
| Anixa Biosciences Inc | Michael J. Catelani | President, COO, & CFO | Purchase of securities on an exchange or from another person at price $ 2.40 per share. | 07 Jun 2024 | 6,250 | 35,211 (0%) | 0% | 2.4 | 15,000 | Common Stock |
| Anixa Biosciences Inc | Michael J. Catelani | President, COO, & CFO | Grant, award, or other acquisition of securities at price $ 2.52 per share. | 30 Apr 2024 | 1,189 | 28,961 (0%) | 0% | 2.5 | 2,996 | Common Stock |
| Anixa Biosciences Inc | J. Catelani Michael | President, COO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 350,000 | 350,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Michael J. Catelani | President, COO & CFO | Purchase of securities on an exchange or from another person at price $ 3.64 per share. | 20 Jul 2023 | 5,500 | 26,655 (0%) | 0% | 3.6 | 20,020 | Common Stock |
| Anixa Biosciences Inc | Michael J. Catelani | President, COO & CFO | Grant, award, or other acquisition of securities at price $ 3.47 per share. | 28 Apr 2023 | 865 | 21,155 (0%) | 0% | 3.5 | 3,002 | Common Stock |
| Anixa Biosciences Inc | Michael J. Catelani | President, COO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 350,000 | 350,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Michael J. Catelani | President, COO & CFO | Other type of transaction at price $ 2.81 per share. | 31 Oct 2022 | 1,069 | 20,290 (0%) | 0% | 2.8 | 3,004 | Common Stock |
| Anixa Biosciences Inc | Michael J. Catelani | President | Other type of transaction at price $ 2.76 per share. | 29 Apr 2022 | 1,086 | 19,221 (0%) | 0% | 2.8 | 2,997 | Common Stock |
| Anixa Biosciences Inc | Michael J. Catelani | President | Purchase of securities on an exchange or from another person at price $ 2.66 per share. | 21 Apr 2022 | 5,500 | 18,135 (0%) | 0% | 2.7 | 14,630 | Common Stock |
| Anixa Biosciences Inc | Michael J. Catelani | President | Purchase of securities on an exchange or from another person at price $ 2.53 per share. | 20 Apr 2022 | 2,509 | 12,635 (0%) | 0% | 2.5 | 6,348 | Common Stock |
| Anixa Biosciences Inc | Michael J. Catelani | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Michael J. Catelani | COO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 500,000 | 500,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Michael J Catelani | COO & CFO | Other type of transaction at price $ 4.04 per share. | 29 Oct 2021 | 743 | 10,126 (0%) | 0% | 4.0 | 3,002 | Common Stock |
| Anixa Biosciences Inc | Michael J Catelani | COO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Michael J Catelani | COO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Michael J Catelani | COO & CFO | Other type of transaction at price $ 1.84 per share. | 30 Apr 2021 | 1,634 | 9,383 (0%) | 0% | 1.8 | 3,007 | Common Stock |
| Anixa Biosciences Inc | Michael J Catelani | COO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2020 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Michael J Catelani | COO & CFO | Other type of transaction at price $ 1.56 per share. | 31 Oct 2020 | 1,918 | 7,749 (0%) | 0% | 1.6 | 2,992 | Common Stock |